企業プロフィール
Orgenesis 株価・ニュース・カタリスト
- ティッカー:
- ORGS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.10 USD (+205.81%)
終値
最終更新: 2026年8月20日
—
時価総額
株価変動の要因
Current closing-price context is not available for ORGS.
企業概要
事業概要
Orgenesis is a cell-therapy and advanced-manufacturing company focused on decentralized manufacturing, point-of-care cell processing, and enabling infrastructure for regenerative medicine. Its story blends therapeutic ambition with platform and services capability.
所在地とセクター分類
Orgenesis is headquartered in the United States and listed on NASDAQ, with a global and platform-oriented biotech profile. It sits between cell therapy, manufacturing services, and biotech infrastructure.
ビジネスモデルの特徴
The business model depends on platform partnerships, manufacturing solutions, and the ability to commercialize decentralized cell-therapy workflows. Investors watch strategic deals, platform adoption, and the company's ability to translate infrastructure into revenue.
バイオ業界での位置付け
Orgenesis occupies a niche infrastructure position within biotech. It is less of a classic drug stock and more of a platform-enablement story tied to cell therapy manufacturing.
今後のカタリスト
- Orgenesis’ catalysts are cell-therapy manufacturing, point-of-care platform execution, and any update that clarifies how the company is monetizing its assets. The story is still mostly about platform commercialization.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。